Zai Lab
Laura Fabiano brings extensive administrative support experience in various high-stakes environments, currently serving as Executive Assistant to the President and Chief Operating Officer at Zai Lab since December 2021. Prior roles include providing administrative assistance at Wilson Sonsini Goodrich & Rosati, Latham & Watkins, and CDM Smith, where responsibilities ranged from calendar management and event planning to overseeing legal documentation and managing travel arrangements. Laura has also held positions in the social services sector, working as a Transitional Living Specialist and Case Manager, equipping youth with essential life skills. Educational qualifications include a B.A. in Economics from the University of Vermont and an M.Ed. in School Counseling from Salem State University.
This person is not in any teams
This person is not in any offices
Zai Lab
5 followers
Zai Lab Ltd is a biopharmaceutical company. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include three drug candidates with greater China rights and three drug candidates with global rights. The greater China rights drug candidates include Niraparib (ZL-2306), Omadacycline (ZL-2401) and ZL-2301. The global rights drug candidates include Fugan (ZL-3101), ZL-2302 and ZL-1101.